ArticleAmerican journal of cancer research2017

Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells.

Norihiko Suzuki et al.PubMed ↗Full text ↗

No numbers read from the abstract.